Sota Kato
Kita, 3319530, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Testing the power-law hypothesis of the interconflict interval.
Journal: Scientific reports
Published: October 11, 2023
Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach.
Journal: Bioorganic & medicinal chemistry letters
Published: September 14, 2023
Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor.
Journal: Bioorganic & medicinal chemistry
Published: July 04, 2023
Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor.
Journal: Bioorganic & medicinal chemistry letters
Published: September 21, 2022
Visualization of the Necking Initiation and Propagation Processes during Uniaxial Tensile Deformation of Crystalline Polymer Films via the Generation of Fluorescent Radicals.
Journal: ACS macro letters
Published: May 16, 2022
TP0463518 (TS-143) Ameliorates Peptidoglycan-Polysaccharide Induced Anemia of Inflammation in Rats.
Journal: Biological & pharmaceutical bulletin
Published: November 01, 2021
Non-symmetric mechanophores prepared from radical-type symmetric mechanophores: bespoke mechanofunctional polymers.
Journal: Chemical communications (Cambridge, England)
Published: February 22, 2021
A Diarylacetonitrile as a Molecular Probe for the Detection of Polymeric Mechanoradicals in the Bulk State through a Radical Chain-Transfer Mechanism.
Journal: Angewandte Chemie (International ed. in English)
Published: September 29, 2020
Crystallization-induced mechanofluorescence for visualization of polymer crystallization.
Journal: Nature communications
Published: May 29, 2020
Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-α Stabilization.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: May 19, 2020
DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 19, 2019
TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 21, 2019
Last Updated: 09/26/2026